Immunome to Present at the Jefferies Healthcare Conference
Immunome, Inc. (NASDAQ: IMNM) has announced that its President and CEO, Purnanand Sarma, PhD, will present at the Jefferies Healthcare Conference on June 9 at 2:30 p.m. ET. The event will be accessible via a live audio webcast on the company's website, with a replay available for 90 days post-event. Immunome focuses on developing first-in-class antibody therapeutics using its human memory B cell platform, targeting oncology and infectious diseases, including COVID-19. For more details, visit www.immunome.com.
- None.
- None.
Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company’s website at www.immunome.com. The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.
About
Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements” intended to qualify for the “safe harbor” from liability established by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements may be identified by the words “will,” “anticipate,” believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “may,” “could,” “should,” “seek,” “potential” and similar expressions. Forward-looking statements are based on Immunome’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, many of which are outside of Immunome’s control, including the risks and uncertainties set forth under the caption “Risk Factors” in Immunome’s Annual Report on Form 10-K filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005297/en/
Immunome Contact
Chief Financial Officer
investors@immunome.com
Investor Contact
Managing Director
laurence@gilmartinir.com
Media Contact
Account Supervisor
gschanker@lifescicomms.com
Source:
FAQ
What is Immunome's presentation date at the Jefferies Healthcare Conference?
Who will represent Immunome at the Jefferies Healthcare Conference?
How can I access the webcast of Immunome's presentation?
What is Immunome's focus in biopharmaceutical development?